SCHEMBL1775467

SCHEMBL1775467

NC(=O)OC1CCN(c2cc(Cl)nc(N)n2)CC1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.64
▸ MAPT P10636 3/20 0.52
▸ CYP1A2 P05177 3/20 0.52
▸ CYP2D6 P10635 2/20 0.52
▸ KMT2A Q03164 3/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ HTT P42858 3/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.45
▸ S1PR2 O95136 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ GAA P10253 1/20 0.41
▸ HRH4 Q9H3N8 4/20 0.41
▸ NUDT1 P36639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27738442 0.85 LMNA (0.53) LMNAMAPTCYP1A2CYP2D6KMT2A
SCHEMBL26695699 0.81 LMNA (0.48) LMNAMAPTCYP1A2KMT2ASMN1; SMN2
SCHEMBL29283185 0.80 LMNA (0.41) LMNA
SCHEMBL21858189 0.79 LMNA (0.61) LMNAMAPTCYP1A2CYP2D6KMT2A
SCHEMBL28543561 0.77 HRH3 (0.61) HRH4
SCHEMBL5149830 0.77 LMNA (0.58) LMNAMAPTCYP1A2CYP2D6KMT2A
SCHEMBL5153329 0.76 LMNA (0.67) LMNAMAPTCYP1A2CYP2D6KMT2A
SCHEMBL16701665 0.76 LMNA (0.63) LMNAMAPTCYP1A2CYP2D6KMT2A
SCHEMBL21777093 0.75 CYP1A2 (0.40) LMNAMAPTCYP1A2CYP2D6SMN1; SMN2
SCHEMBL26695651 0.74 SPHK1 (0.42) KMT2ASMN1; SMN2MEN1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943628-B2 Pyrimidine derivatives PFIZER LIMITED (GB) 2011-05-17 — — US disclosed
CN-101277951-A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity PALAU PHARMA SA (ES) 2008-10-01 — — CN disclosed
Send feedback